High‐Performance and Uniform 1 cm2 Polymer Solar Cells with D1‐A‐D2‐A‐Type Random Terpolymers

For the commercial development of organic photovoltaics (OPVs), laboratory‐scale OPV technology must be translated to large area modules. In particular, it is important to develop high‐efficiency polymers that can form thick (>100 nm) bulk heterojunction (BHJ) films over large areas with optimal morphologies for charge generation and transport. Here, D₁‐A‐D₂‐A random terpolymers composed of 2,2′‐bithiophene with various proportions of 5,6‐difluoro‐4,7‐bis(thiophen‐2‐yl)‐2,1,3‐benzothiadiazole and 5,6‐difluoro‐2,1,3‐benzothiadiazole (FBT) are synthesized. It is found that incorporating small proportions of FBT into the polymer not only conserves the high crystallinity and favorable face‐on orientation of the D‐A copolymer FBT‐Th4 but also improves the nanoscale phase separation of the BHJ film. Consequently, the random terpolymer PDT2fBT‐BT10 exhibits a much improved solar cell efficiency of 10.31% when compared to that of the copolymer FBT‐Th4 (8.62%). Moreover, due to this polymer's excellent processability and suppressed overaggregation, OPVs with 1 cm² active area based on 351 nm thick PDT2fBT‐BT10 BHJs exhibit high photovoltaic performance of 9.42%, whereas rapid efficiency decreases arise for FBT‐Th4‐based OPVs for film thicknesses above 300 nm. It is demonstrated that this random terpolymer can be used in large area and thick BHJ OPVs, and guidelines for developing polymers that are suitable for large‐scale printing technologies are presented.     

Mesenchymal stromal cell exosome–enhanced regulatory T-cell production through an antigen-presenting cell–mediated pathway

Background aims

The immunomodulatory property of mesenchymal stromal cell (MSC) exosomes is well documented. On the basis of our previous report that MSC exosomes increased regulatory T-cell (Treg) production in mice with allogenic skin graft but not in ungrafted mice, we hypothesize that an activated immune system is key to exosome-mediated Treg production.

Agronomic and chemical performance of field‐grown tobacco engineered for triterpene and methylated triterpene metabolism

Squalene is a linear intermediate to nearly all classes of triterpenes and sterols and is itself highly valued for its use in wide range of industrial applications. Another unique linear triterpene is botryococcene and its methylated derivatives generated by the alga Botryococcus braunii race B, which are progenitors to fossil fuel deposits. Production of these linear triterpenes was previously engineered into transgenic tobacco by introducing the key steps of triterpene metabolism into the particular subcellular compartments. In this study, the agronomic characteristics (height, biomass accumulation, leaf area), the photosynthetic capacity (photosynthesis rate, conductance, internal CO₂ levels) and triterpene content of select lines grown under field conditions were evaluated for three consecutive growing seasons. We observed that transgenic lines targeting enzymes to the chloroplasts accumulated 50–150 times more squalene than the lines targeting the enzymes to the cytoplasm, without compromising growth or photosynthesis. We also found that the transgenic lines directing botryococcene metabolism to the chloroplast accumulated 10‐ to 33‐fold greater levels than the lines where the same enzymes were targeted to in the cytoplasm. However, growth of these high botryococcene accumulators was highly compromised, yet their photosynthesis rates remained unaffected. In addition, in the transgenic lines targeting a triterpene methyltransferase (TMT) to the chloroplasts of high squalene accumulators, 55%–65% of total squalene was methylated, whereas in the lines expressing a TMT in the cytoplasm, only 6%–13% of squalene was methylated. The growth of these methylated triterpene‐accumulating lines was more compromised than that of nonmethylated squalene lines.     

Conserving rare species can have high opportunity costs for common species

Conservation practitioners face difficult choices in apportioning limited resources between rare species (to ensure their existence) and common species (to ensure their abundance and ecosystem contributions). We quantified the opportunity costs of conserving rare species of migratory fishes in the context of removing dams and retrofitting road culverts across 1,883 tributaries of the North American Great Lakes. Our optimization models show that maximizing total habitat gains across species can be very efficient in terms of benefits achieved per dollar spent, but disproportionately benefits common species. Conservation approaches that target rare species, or that ensure some benefits for every species (i.e., complementarity) enable strategic allocation of resources among species but reduce aggregate habitat gains. Thus, small habitat gains for the rarest species necessarily come at the expense of more than 20 times as much habitat for common ones. These opportunity costs are likely to occur in many ecosystems because range limits and conservation costs often vary widely among species. Given that common species worldwide are declining more rapidly than rare ones within major taxa, our findings provide incentive for triage among multiple worthy conservation targets.     

Optimizing performance of semi‐continuous cell culture in an ambr15™ microbioreactor using dynamic flux balance modeling

The ambr bioreactors are single‐use microbioreactors for cell line development and process optimization. With operating conditions for large‐scale biopharmaceutical production properly scaled down, microbioreactors such as the ambr15? can potentially be used to predict the effect of process changes such as modified media or different cell lines. While there have been some recent studies evaluating the ambr15? technology as a scale‐down model for fed‐batch operations, little has been reported for semi‐continuous or continuous operation. Gassing rates and dilution rates in the ambr15? were varied in this study to attempt to replicate performance of a perfusion process at the 5 L scale. At both scales, changes to metabolite production and consumption, and cell growth rate and therapeutic protein production were measured. Conditions were identified in the ambr15? bioreactor that produced metabolic shifts and specific metabolic and protein production rates that are characteristic of the corresponding 5 L perfusion process. A dynamic flux balance (DFB) model was employed to understand and predict the metabolic changes observed. The DFB model predicted trends observed experimentally, including lower specific glucose consumption and a switch from lactate production to consumption when dissolved CO₂ was maintained at higher levels in the broth. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 34:420–431, 2018     

Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids

1. Download high-res image (233KB)
2. Download full-size image